BRIM Biotechnology, Inc.

NT$26.65As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6885Healthcare
Country Taiwan
PE (Fwd) •••
TSR 4Y CAGR 1.75%
Div yield —
ROE (26.52%)
Biotechnology
Beta (5Y) 0.74
PE TTM —
TSR TTM (11.90%)
Mkt cap NT$3.546B
ROIC (16.35%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$30
11.59%
(73.80%)
Hold 8|10|8|1|3
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.43
0.47
0.50
0.50
18.77%
26.23%
26.37%
17.16%
RevenueNT$M
188.7
188.7
194.4
202.2
10.01%
4.67%
9.08%
8.96%
Peers (US$107.1M)
Cap (US$)
PE
102.2M
10.25x
Capital
TTM
5Y
10Y
Leveragex
1.139
(1.028)
(0.964)
EBIT/Intx
0.252
0.387
0.374
Own earn%
(141.08)
109.84
80.53
Sh yield%
37.18
52.53
52.91
Owners
Insiders/Inst%
5.89
85.82
Short interest%
3.94
SBC / revenue%
1.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
0–7
$1 testx
—
Incr. ROIC%
8